|
| CD3+CD69+ | CD4+CD69+ | CD8+CD69+ | CD3+HLA-DR+ | |||||
rhoa | p | rhoa | p | rhoa | p | rhoa | p | |||
Gal-3 | Controls (n = 42) | 0.107 | 0.592 | 0.088 | 0.65 | −0.228 | 0.25 | 0.008 | 0.96 | |
Patients (n = 37) | S1 | 0.268 | 0.279 | 0.443 | <0.05 | −0.196 | 0.39 | 0.364 | 0.11 | |
S2 | −0.172 | 0.479 | 0.149 | 0.53 | 0.260 | 0.28 | −0.377 | 0.12 | ||
S3 | 0.318 | 0.314 | −0.291 | 0.35 | 0.291 | 0.35 | 0.036 | 0.90 |